Induction of anti-tumor immunity and T-cell responses using nanodelivery systems engrafting TLR-5 ligand

Expert Review of Vaccines

Volumn 10, Issue 2, 2011, Pages 155-157

  Panda, Amulya K ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

anti tumor immunity; dendritic cells; flagellin; liposome; T cell response; vaccine

Indexed keywords

DENDRITIC CELL VACCINE; FLAGELLIN; SYNTHETIC PEPTIDE; TOLL LIKE RECEPTOR 5;

ADAPTIVE IMMUNITY; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CELL MATURATION; INNATE IMMUNITY; LIPOSOMAL DELIVERY; NANOANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; VACCINATION;

EID: 79951930479     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.164     Document Type: Review

References (12)

1. Plotkin SA. Vaccines: the fourth Century. Clin. Vaccine Immunol. 16(12), 1709-1719 (2009)
2. Zinkernagal RM. On natural and artificial vaccinations. Ann. Rev. Immunol. 21, 515-546 (2003)
3. Look M, Bandyopadhyay A, Blum JS, et al. Application of nanotechnologies for improved immune response against infectious diseases in the developing world. Adv. Drug Deliv. Rev. 62(4-5), 378-393 (2010)
4. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4, 145-160 (2005) (Pubitemid 40282557)
5. Klippstein R, Pozo D. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomedicine 6(4), 523-529 (2010)
6. Nordly P, Agger EM, Andersen P, Nielsen HM, Foged C. Incorporation of the TLR4 agonist monophosphoryl lipid a into the bilayer of DDA/TDB liposomes: physico-chemical characterization and induction of CD8(+) T-cell responses. In Vivo. Pharm. Res. DOI: 10.1007/s11095-010-0301-9 (2010) (Epub ahead of print)
7. Mizel SB, Bates JT. Flagellin as an adjuvant: cellular mechanisms and potential. J. Immunol. 185(10), 5677-5682 (2010)
8. Faham A, Altin JG. Antigen-containing liposomes engrafted with flagellin-related peptides are effective vaccines that can induce potent antitumor immunity and immunotherapeutic effect. J. Immunol. 185(3), 1744-1754 (2010)
9. Palucka K, Banchereau J, Mellman I. Designing vaccines based on biology of human dendritic cells subsets. Immunity 33, 464-478 (2010)
10. Kanchan V, Panda AK. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 28(35), 5344-5357 (2007) (Pubitemid 47532191)
11. Oyewumi MO, Kumar A, Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert. Rev. Vaccines 9(9), 1095-1107 (2010)
12. Rettig L, Haen SP, Bittermann AG, et al. Particle size and activation threshold: a new dimension of danger signalling. Blood 115(22), 4533-4541 (2010)